Search results
The night basketball stopped: How NBA Twitter reacted to the league suspension four years ago
Hoops Hype via Yahoo Sports· 2 months agoFour years ago, the basketball world came to a screeching halt when bombshell news dropped: Rudy...
Here's Why Moderna May Dominate the Vaccine Market This Fall
Motley Fool· 2 years agoModerna (NASDAQ: MRNA) shares climbed more than 2% yesterday after the company took a big step...
Is Novavax a Buy Now?
Motley Fool via Yahoo Finance· 2 months agoNovavax (NASDAQ: NVAX) has taken investors on a roller coaster ride over the past week or so. The stock soared after the company settled a dispute with a...
FDA grapples with whether to modify COVID vaccine for fall
LA Times via Yahoo News· 2 years agoThe Food and Drug Administration will debate Tuesday whether it's time to update COVID vaccine...
Meet the Black students who were instrumental in developing the first Covid-19 shots
CNN via Yahoo News· 8 months agoIt was a meeting that changed their lives forever. The year was 2020, and reports had emerged from...
Fact check: False claims about Pfizer vaccine stem from company's release of 80,000 pages of...
USA TODAY via Yahoo News· 2 years agoThe claim: 80,000 pages of Pfizer data show the vaccine has a 12% efficacy rate, harms fetuses As...
The Most Common Side Effects Of The New Bivalent COVID Booster
HuffPost Life via Yahoo News· 2 years agoHere's what you can expect when you get the bivalent COVID shot. (Photo: filadendron via Getty...
Fact check: New COVID-19 variants continue to be discovered
USA TODAY via Yahoo News· 1 year agoThe claim: COVID-19 variants are no longer being found An April 7 Instagram post (direct link,...
Will we be prepared for "Disease X?" Misinformation could leave us vulnerable to a future pandemic
Salon via Yahoo News· 3 months agoTEK IMAGE/SCIENCE PHOTO LIBRARY / Getty Images Pandemics have always been a major part of human...
This Could be Novavax's Big Opportunity
Motley Fool· 7 months agoEarly on in the pandemic, Moderna and Pfizer beat smaller rival Novavax (NASDAQ: NVAX) to market with their coronavirus vaccines by a year or more in...
